Article
Lack of tacrolimus circadian pharmacokinetics and CYP3A5 pharmacogenetics in the early and maintenance stages in Japanese renal transplant recipients.
British journal of clinical pharmacology - 1 Aug 2008
Satoh Shigeru, Kagaya Hideaki, Saito Mitsuru, Inoue Takamitsu, Miura Masatomo, Inoue Kazuyuki, Numakura Kazuyuki, Tsuchiya Norihiko, Tada Hitoshi, Suzuki Toshio, Habuchi Tomonori
Abstract excerpt
AIMS: We investigated whether tacrolimus pharmacokinetics shows circadian variation and the influence of the CYP3A5 A6986G polymorphism on the pharmacokinetics in both the early and maintenance stages after renal transplantation. METHODS: Tacrolimus was administered twice daily at specified times (09.00 and 21.00 h) throughout the pre- and post-transplant period according to the trough-targeting strategy. Fifty...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
